粪便总胆汁酸酶循环法在全自动生化分析仪上的验证
本研究依据CLSI指南和欧盟IVD法规,在粪便基质中评估DiaSys「Total bile acids 21 FS」试剂的分析性能,并与IDK®微孔板试剂盒比较122份患者粪便样本。结果显示该法在3.5–130 μmol/L内线性良好,CVs为1.7%–3.5%,与IDK®相关性达r=0.988,但单个胆汁酸定量存在差异。
要点
- 酶循环法可在全自动生化分析仪上用于粪便总胆汁酸常规检测。
- 该方法在3.5–130 μmol/L内线性良好,总精密度CV为3.5%。
- 与IDK®法相关性好(r=0.988),但单个胆汁酸定量存在差异。
核心结论
- 全自动生化平台上的酶法总胆汁酸分析可用于粪便样本的常规检测。
- 循环酶法可能需要考虑粪便胆汁酸池组成的参考标准品。
研究设计与样本
- 依据CLSI指南和EU-IVD法规(2017/745)评估DiaSys「Total bile acids 21 FS」试剂在粪便基质中的性能。
- 与IDK®微孔板试剂盒比较,测量患者粪便样本n=122。
- 采用Passing-Bablok和Bland-Altman分析评估方法一致性。
- 以HPLC-MS/MS为参考方法评估八种单个胆汁酸的定量。
主要发现
- DiaSys法在3.5–130 μmol/L内线性良好。
- 重复性、总精密度和重现性CVs分别为1.7%、3.5%和3.0%。
- LoB≤0.17 μmol/L,LoD≤0.3 μmol/L,LoQ为3.5 μmol/L。
- 未观察到内源性物质的显著干扰。
- 两法在高达140 μmol/L范围内相关性好(r=0.988),但单个胆汁酸定量存在差异,平均偏差分别为7%(DiaSys)和31%(IDK®)。
关键数值与推荐
- 线性范围3.5–130 μmol/L。
- 重复性CV 1.7%,总精密度CV 3.5%,重现性CV 3.0%。
- LoB≤0.17 μmol/L,LoD≤0.3 μmol/L,LoQ 3.5 μmol/L。
- 与IDK®法相关性r=0.988(上限140 μmol/L)。
- 平均偏差:DiaSys 7%,IDK® 31%。
临床怎么用
- 可在全自动临床化学分析仪上采用酶循环法检测粪便总胆汁酸。
- 需注意不同方法对单个胆汁酸定量存在差异。
局限性
- 循环酶法可能需要参考标准品以考虑粪便胆汁酸池组成。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Bile acid diarrhea is a common but underdiagnosed condition. Because the gold standard test (75SeHCAT) is time-consuming and not widely available, fecal bile acid excretion is typically assessed by chromatography and mass spectrometry. Although enzymatic cycling assays are well established for the rapid and cost-effective analysis of total bile acids (TBA) in serum or plasma, their full potential has yet not been extended to stool samples in clinical routine. METHODS: The performance of the 'Total bile acids 21 FS' reagent (DiaSys) was evaluated in fecal matrix according to CLSI guidelines and EU-IVD Regulations (2017/745), and compared to an established microplate-based kit (IDK®) by measuring patient stool samples (n=122). Method agreement was assessed by Passing-Bablok and Bland-Altman analysis. The quantification of eight individual BAs was assessed using HPLC-MS/MS as reference method. RESULTS: The DiaSys assay showed linearity between 3.5 and 130 μmol/L, good repeatability, total precision, and reproducibility with CVs of 1.7 %, 3.5 %, and 3.0 %. Limit of blank (LoB), detection (LoD), and quantitation (LoQ) were ≤0.17, ≤0.3, and 3.5 μmol/L, respectively. No significant interference from endogenous substances was observed. The methods showed good correlation up to 140 μmol/L (r=0.988), despite differences in the quantification of individual BAs, with mean deviations of 7 % (DiaSys) and 31 % (IDK®), respectively. CONCLUSIONS: The advantages of enzymatic TBA analysis on fully automated clinical chemistry platforms can be exploited for the routine analysis of stool samples. However, cycling assays may benefit from reference standards that take into account the composition of the fecal BA pool.
引用
- Masetto A, Leber T, Frömel T, et al. Towards routine high-throughput analysis of fecal bile acids: validation of an enzymatic cycling method for the quantification of total bile acids in human stool samples on fully automated clinical chemistry analyzers. Clin Chem Lab Med. 2025. PMID: 39840591. doi:10.1515/cclm-2024-1414
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。